Newly Diagnosed with Lung Cancer: Your First Steps

A lung cancer diagnosis brings unfamiliar medical words, appointments, and treatment choices. This guide explains what to expect - what tests involve, how staging works, and how to make informed decisions.

Most people newly diagnosed with lung cancer have a few weeks before treatment starts. Use this time to understand your diagnosis and, if you choose, to get a second opinion before deciding on treatment.

Five First Steps After a Lung Cancer Diagnosis

1. Read your pathology report and confirm whether you have NSCLC or SCLC.
2. Complete all recommended staging scans - usually a CT scan and a PET-CT.
3. Ask your oncologist whether biomarker testing has been ordered.
4. Ask whether a multidisciplinary tumor board has reviewed or will review your case.
5. Consider a second opinion before committing to a treatment plan.

What Your Pathology Report Shows

Your diagnosis starts with a biopsy - doctors take a small tissue sample from the suspected tumor and a pathologist examines it under a microscope. Doctors may collect the sample through a needle, a bronchoscope (a thin camera tube they pass through your airways), or a small surgical procedure. The pathologist writes a report describing what the cells look like, how abnormal they are, and which markers are present.

The American Cancer Society breaks down each section of a lung pathology report in plain language, which can help you prepare for the conversation with your oncologist. The most important finding at this stage is the cancer type - because every treatment decision that follows depends on it.

The Two Main Types of Lung Cancer

Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancer diagnoses, according to the American Cancer Society. NSCLC includes three subtypes:

• Adenocarcinoma - the most common subtype, usually found in the outer parts of the lung.
• Squamous cell carcinoma - most often found in the central airways, close to the main bronchi.
• Large cell carcinoma - a less common subtype that can appear anywhere in the lung.

Small cell lung cancer (SCLC) makes up the remaining cases. SCLC grows faster and spreads earlier than NSCLC. Smoking is the main risk factor for SCLC. Your doctors need to know which type you have because it changes your entire treatment plan.

How Doctors Stage Your Lung Cancer

Staging describes how far your cancer has spread. This information guides every major decision your care team makes - whether surgery is an option, which medicines will work, and whether radiation is needed.

Most lung cancers are staged using the TNM system. T stands for the size and local spread of the primary tumor. N describes whether cancer has reached nearby lymph nodes. M indicates whether the cancer has metastasized - spread to distant sites such as the liver, bones, brain, or the other lung. The NCI SEER program explains how T, N, and M factors combine to assign a stage.

Your doctor assigns a stage from I to IV based on those three factors. Stage I cancer stays in the lung. Stage II cancer may grow larger or spread to nearby lymph nodes. Stage III involves lymph nodes in the centre of the chest or nearby structures. Stage IV means cancer has spread to another organ or the lining of the lung or heart. Your stage guides treatment decisions, and other factors matter too - genetic features, your health, and how your cancer responds to treatment.

Staging Tests: What to Expect in the First Weeks

After diagnosis, you will likely have several imaging tests and possibly additional procedures to complete staging. Here is what each one typically involves.

CT scan of the chest and abdomen. This is the first scan doctors order. A CT scan creates detailed cross-sectional images of the tumor, the lymph nodes around the chest, and nearby organs. You may have already had a CT scan before the biopsy - your team may order another after diagnosis to see the complete picture.

PET-CT scan. A PET-CT combines two types of imaging in one session. Before the scan, you receive a small injection of a mildly radioactive sugar solution. Cancer cells tend to absorb that solution faster than normal tissue, making them easier to spot on the scan. PET-CT is useful for checking whether cancer has spread to lymph nodes or distant organs. If you want to understand exactly what this scan involves, the detailed guide to PET-CT scans in cancer diagnosis explains what happens before, during, and after the test.

Brain MRI. Because some lung cancers can spread to the brain, your team may order an MRI of the head - especially if you have neurological symptoms or if your cancer is at a later stage.

Endobronchial ultrasound (EBUS). If doctors haven't determined whether cancer reached the lymph nodes in your chest, they may use a bronchoscope fitted with an ultrasound probe to sample those nodes. They perform this under sedation, which makes it less invasive than surgery.

Additional imaging. Depending on your symptoms and initial scan results, your team may order further tests to check for spread to specific areas, such as the bones.

Why Biomarker Testing Matters

If you have NSCLC - especially adenocarcinoma - biomarker testing is crucial in the weeks after diagnosis. It's sometimes missed at busy practices, so ask about it directly.

Biomarker testing, also called molecular or genomic testing, looks for specific genetic mutations or protein markers in your tumor cells. The results can show whether targeted therapies or immunotherapy will work for your cancer. The NCI guide to non-small cell lung cancer treatment outlines how mutation status shapes treatment recommendations at each stage.

Common markers tested in NSCLC include:

• EGFR - a protein that appears in high amounts on the surface of 10% to 20% of NSCLC cells, according to the American Cancer Society. Targeted drugs exist for tumors with EGFR mutations.
• ALK - a gene rearrangement found in roughly 5% of NSCLCs, according to the American Cancer Society. Targeted medicines are available for ALK-positive lung cancer.
• ROS1, KRAS, BRAF, MET, RET, NTRK - other gene changes that may make you eligible for specific targeted medicines or clinical trials.
• PD-L1 - a protein marker that helps predict whether immunotherapy may be effective.

If your oncologist hasn't mentioned biomarker testing, ask about it directly. To learn more about what these results mean for your care, the guide to what your tumor's molecular profile means for treatment explains how genetic findings affect treatment decisions.

Testing usually requires a sample from your biopsy. In some cases, a blood test (called liquid biopsy) can find certain mutations without tissue. Ask your team which approach they're using and when you'll get results.

Building Your Lung Cancer Care Team

Lung cancer care is rarely managed by one doctor alone. A well-rounded team often includes:

• A thoracic oncologist - a cancer specialist who focuses on cancers of the lung and chest.
• A pulmonologist - a lung specialist who may have been involved in your initial diagnosis.
• A thoracic surgeon - if surgery may be part of your plan.
• A radiation oncologist - who plans and oversees any radiation treatment.
• A palliative care specialist - focused on managing symptoms and side effects alongside active treatment (palliative care is active support, not a last resort).

Many cancer centers hold multidisciplinary tumor board meetings where specialists review your case and agree on a treatment plan. If you're not sure whether your case went through a tumor board, ask your team.

Should You Get a Second Opinion Before Treatment Starts?

A second opinion is standard practice. Your doctor won't see it as a lack of trust. Many oncologists expect their patients to seek one, especially before a major treatment decision.

For lung cancer specifically, a second review may confirm that biomarker testing was complete, identify a clinical trial you weren't told about, or suggest a different treatment order. Some changes after a second opinion are small. Some are significant. Either way, an independent review gives you confidence in your decision.

You don't need to travel for a second opinion. Verified oncologists can review your scans, pathology report, and staging results remotely. An overview of lung cancer treatment options and when to seek a second opinion explains what a thoracic oncologist looks for when reviewing a new case and how to prepare your records in advance.

When you're ready, you can upload your reports and connect with a verified oncologist at HealthUnwired for a video consultation - most happen within 48 hours, without traveling.

When to Talk to Your Doctor

Contact your care team right away if you develop new or worsening symptoms while waiting for staging results. These include increased breathlessness, coughing up blood, sudden chest pain, new bone pain, or any change in vision, speech, or balance. Don't wait for your next scheduled appointment if any of these happen.

Also speak to your team if:

• You don't understand any part of your pathology report or staging results.
• Biomarker testing has not been discussed and your cancer type is NSCLC.
• You feel pressured to make a treatment decision before you have had time to ask all your questions.
• You would like a referral for a second opinion and are unsure how to raise it.

This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.